NCT03284970View on ClinicalTrials.gov

Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

August 23, 2017

Primary Completion Date

May 11, 2018

Study Completion Date

May 11, 2018

Conditions
Relapsing-Remitting Multiple Sclerosis
Trial Locations (1)

02035

Neurology Center of New England, Foxborough

All Listed Sponsors
collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

EMD Serono Research & Development Institute, Inc.

INDUSTRY

NCT03284970 - Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes | Biotech Hunter | Biotech Hunter